Highlights
PETNET SolutionsDelivering a broad portfolio of PET radiopharmaceuticals to advance patient outcomes
PETNET Solutions Inc, A Siemens Healthineers Company, reliably delivers PET radiopharmaceuticals via the largest network of cyclotron-equipped radiopharmacies globally. Supported by experts averaging more than 20 years of industry experience, PETNET customers unlock access to a wide array of tracers, customized data analytics, and educational resources to drive growth.
POSLUMA® (flotufolastat F 18) injection is here
Available through an agreement between Blue Earth Diagnostics and PETNET Solutions, Inc.
For accurate service information for your specific location, please contact our Customer Care Team at +1 (877) 473-8638 or customercare@petnetsolutions.com.
Expanding access nation-wide
POSLUMA, formerly known as 18F-rhPSMA-7.3, is now approved to be manufactured and distributed from 36 PETNET radiopharmacy sites across the USA. Commercial availability may vary according to individual state regulatory agencies.
Our portfolio
Broadest portfolio of PET radiopharmaceuticals
Whether your focus is on clinical care or investigational research, PETNET offers the broadest portfolio of PET radiopharmaceuticals manufactured and delivered from a single supplier:
- Ammonia N 13 Injection
- AMYViD® (florbetapir F 18 injection)
- Axumin® (fluciclovine F 18 injection)
- Cerianna™ (fluoroestradiol F 18) injection
- Fludeoxyglucose (FDG) F 18 injection
- POSLUMA® (flotufolastat F 18) injection
- Sodium fluoride F 18 injection
- TAUVID™ (flortaucipir F 18 injection)
Axumin® and POSLUMA® are registered trademarks owned or licensed by Blue Earth Diagnostics.
Cerianna™ is a trademark owned or licensed by GE HealthCare Technologies Inc., its subsidiaries and/or affiliates.
AMYViD® is a registered trademark and TAUVID™ is a trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
Who we are
47 PETNET radiopharmacies worldwide
PETNET Solutions Inc.
Delivering from the largest global PET radiopharmacy network
With 47 cyclotron-powered radiopharmacies around the globe, PETNET is the largest supplier of positron emission tomography (PET) radiopharmaceuticals.
We manufacture and deliver more than 1,345,000 doses1 to more than 2,800 imaging centers1 each year. In the United States alone, we deliver at least one product to 92% of PET imaging centers.2
Contract manufacturer of choice
Our global footprint, quality leadership, and broad portfolio expertise make us the ideal choice for IP holders working to bring new agents to market.
We have demonstrated leadership in the PET regulatory space. We submitted and obtained FDA approval of 18F-FDG well in advance of industry requirements and continue to work closely with the FDA as new technology appears and the PET industry evolves.
And as a key part of Siemens Healthineers Molecular Imaging, we have a direct line into front-line research and development in the world of molecular imaging.
Clinical trial guidance
Customers in the United States have unique opportunities to participate in clinical trials with the support of PETNET.
We are always collaborating with pharmaceutical companies to research new agents and submit drug applications. In addition to providing access to radiopharmaceuticals, we provide the training and support needed to participate in clinical trials across the United States.
More than 10 million doses delivered since 2011
PETNET maintains a dose fulfilment rate of >99% through our integrated network of radiopharmacies. We know it can be challenging to maintain patient schedules, minimize wait times, and provide timely results to referring physicians without PET tracer delivery you can count on.
Engineered
reliability
Heavy investments in equipment design and redundancy increase uptime and output, upgrade cyclotron RF technology, and advance targetry, ion output, and control systems technologies.
Proven on-time
delivery
We use automated production, route optimization, and GPS technology to support on-time delivery in the US.
Leading high quality production
Updates to our pharmacy information management system help ensure product quality and patient safety for customers within the US.
Ongoing infrastructure investments
We are committed to continuing to invest heavily in our radiopharmacy sites to increase capacity, output, and operational efficiency. Last year, we opened 2 replacement radiopharmacy sites (and upgraded equipment, including cyclotrons, in several others).
Read about our ongoing investments:
Expert support
PETNET's knowledgeable staff averaging more than 20 years of industry experience supports your imaging practice and encourages growth. You can rely on our high performance customer care, pharmacy, and sales teams for ordering and scheduling support, market development, and strategic account engagement.
Start imaging with POSLUMA® (flotufolastat F 18) injection
1
FY22 total dose delivery, data on file
2
Based on 2020 IMV data and internal records
Axumin® and POSLUMA® are registered trademarks owned or licensed by Blue Earth Diagnostics.
Cerianna™ is trademark owned or licensed by GE HealthCare Technologies Inc., its subsidiaries and/or affiliates.
AMYViD® is a registered trademark and TAUVID™ is a trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
Cerianna™ is trademark owned or licensed by GE HealthCare Technologies Inc., its subsidiaries and/or affiliates.
AMYViD® is a registered trademark and TAUVID™ is a trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.